Risk acceptance in multiple sclerosis patients on natalizumab treatment.
Tur C, Tintoré M, Vidal-Jordana Á, Bichuetti D, Nieto González P, Arévalo MJ, Arrambide G, Anglada E, Galán I, Castilló J, Nos C, Río J, Martín MI, Comabella M, Sastre-Garriga J, Montalban X.
Tur C, et al.
PLoS One. 2013 Dec 10;8(12):e82796. doi: 10.1371/journal.pone.0082796. eCollection 2013.
PLoS One. 2013.
PMID: 24340060
Free PMC article.
Clinical Trial.